The AMPK–mTOR axis as a central regulator of cellular metabolism and physiology

Authors

  • Aswin Rafif Khairullah Research Center for Veterinary Science, National Research and Innovation Agency (BRIN), Jl. Raya Bogor Km. 46 Cibinong, Bogor, West Java, 16911, Indonesia
  • Riza Zainuddin Ahmad Research Center for Veterinary Science, National Research and Innovation Agency (BRIN), Jl. Raya Bogor Km. 46 Cibinong, Bogor, West Java, 16911, Indonesia
  • Eny Martindah Research Center for Veterinary Science, National Research and Innovation Agency (BRIN), Jl. Raya Bogor Km. 46 Cibinong, Bogor, West Java, 16911, Indonesia
  • Dea Anita Ariani Kurniasih Research Center for Public Health and Nutrition, National Research and Innovation Agency (BRIN), Jl. Raya Bogor Km. 46 Cibinong, Bogor, West Java, 16911, Indonesia
  • Bantari Wisynu Kusuma Wardhani Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Jl. Raya Bogor Km. 46 Cibinong, Bogor, West Java, 16911, Indonesia
  • Fadhila Utari Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Jl. Raya Bogor Km. 46 Cibinong, Bogor, West Java, 16911, Indonesia
  • Ilma Fauziah Ma’ruf Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Jl. Raya Bogor Km. 46 Cibinong, Bogor, West Java, 16911, Indonesia
  • Bima Putra Pratama Research Center for Process Technology, National Research and Innovation Agency (BRIN), South Tangerang, Banten 15314, Indonesia
  • Mohammad Sukmanadi Division of Basic Veterinary Medicine, Faculty of Veterinary Medicine, Universitas Airlangga, Kampus C Mulyorejo, Jl. Dr. Ir. H. Soekarno, Surabaya, East Java, 60115, Indonesia
  • Arif Nur Muhammad Ansori Postgraduate School, Universitas Airlangga, Kampus B Dharmawangsa, East Java, 60286, Indonesia
  • Muhammad ‘Ahdi Kurniawan Zoonotic Pathogens and Global Health Research Group, Virtual Research Center for Bioinformatics and Biotechnology (VRCBB), Surabaya, East Java, 60493, Indonesia
  • Sri Mulyati Division of Veterinary Reproduction, Faculty of Veterinary Medicine, Universitas Airlangga, Kampus C Mulyorejo, Jl. Dr. Ir. H. Soekarno, Surabaya, East Java, 60115, Indonesia
  • Wita Yulianti Research Center for Biota Systems, National Research and Innovation Agency (BRIN), Jl. Raya Bogor Km. 46 Cibinong, Bogor, West Java, 16911, Indonesia
  • Imam Mustofa Division of Veterinary Reproduction, Faculty of Veterinary Medicine, Universitas Airlangga, Kampus C Mulyorejo, Jl. Dr. Ir. H. Soekarno, Surabaya, East Java, 60115, Indonesia
  • Abdul Hadi Furqoni Center for Biomedical Research, National Research and Innovation Agency (BRIN), Jl. Raya Bogor Km. 46 Cibinong, Bogor, West Java, 16911, Indonesia
  • Saifur Rehman Department of Pathobiology, Faculty of Veterinary and Animal Sciences, Gomal University, RV9W+GVJ, Indus HWY, Dera Ismail Khan 27000, Pakistan

Keywords:

AMPK, mTOR, cell metabolism, cellular physiology, disease

Abstract

The AMPK–mTOR axis is a central regulator of cellular metabolism that balances catabolic and anabolic pathways according to energy, nutrient, and growth factor status. AMPK acts as an energy sensor, activated when the AMP/ATP ratio increases, which promotes fatty acid oxidation, glucose uptake, and autophagy while suppressing protein synthesis, lipogenesis, and cell proliferation. In contrast, mTORC1 integrates nutrient and growth factor signals to promote protein synthesis, organelle biogenesis, and cell growth when environmental conditions are favorable. The dynamic interplay between AMPK and mTOR enables cells to maintain energy balance, regulate growth and metabolism, and preserve the integrity of their organelles. AMPK–mTOR axis dysregulation has been associated with a number of clinical illnesses, such as cancer, obesity, type 2 diabetes, neurodegenerative diseases, and chronic inflammation. Over-activation of mTORC1 or insufficient AMPK activation can result in insulin resistance, lipid buildup, reduced autophagy, and aberrant cell survival and proliferation. On the other hand, medication or lifestyle changes like mTOR inhibitors, AMPK activators, intermittent fasting, or exercise can help rebalance these pathways, enhance organ function, and lower the chance of disease development. This review aimed to summarize the molecular mechanisms of the AMPK–mTOR axis, its role in cellular metabolism and physiology, and its implications for the therapy of metabolic diseases, cancer, and neurodegenerative disorders. An in-depth knowledge of AMPK–mTOR interactions can serve as the foundation for the creation of precision treatment plans that maintain energy homeostasis in both healthy and diseased states, balance catabolic and anabolic pathways, and improve cellular adaptability.

Downloads

Published

2026-04-01

How to Cite

Khairullah, A. R. ., Ahmad, R. Z. ., Martindah, E., Kurniasih, D. A. A. ., Wardhani, B. W. K. ., Utari, F., Ma’ruf, I. F. ., Pratama, B. P., Sukmanadi, M., Ansori, A. N. M. ., Kurniawan, M. ‘Ahdi, Mulyati, S., Yulianti, W., Mustofa, I., Furqoni, A. H., & Rehman, S. (2026). The AMPK–mTOR axis as a central regulator of cellular metabolism and physiology. Journal of Advanced Veterinary Research, 16(3), 417-426. Retrieved from https://www.advetresearch.com/index.php/AVR/article/view/2527

Issue

Section

Review Article

Most read articles by the same author(s)

1 2 3 4 > >>